What is Angina

What is Angina

DEFINITION
Angina pectoris is characterized by discomfort that occurs when myocardial oxygen demand exceeds supply. Myocardial ischemia can be asymptomatic (silent ischemia), particularly in diabetic patients. Angina can be subdivided as follows: 

1. Chronic (stable)
a. Usually follows a precipitating event (e.g., climbing stairs, sexual intercourse, a heavy meal, emotional stress, cold weather).
b. Generally same severity as previous attacks; relieved by rest or the customary dose of nitroglycerin.
c. Caused by a fixed coronary artery obstruction secondary to atherosclerosis. The presence of one or more obstructions in major coronary arteries is likely; the severity of stenosis is usually more than 70%.
2. Unstable (rest or crescendo)
a. Recent onset.
b. Increasing severity, duration, or frequency of chronic angina.
c. Occurs at rest or with minimal exertion.
3. Vasospastic angina (Prinzmetal's variant)
a. Occurs at rest.
b. Manifests electrocardiographically as episodic ST-segment elevations.
c. Caused by coronary artery spasms with or without superimposed coronary artery disease (CAD).
d. Patients are also more likely to develop ventricular arrhythmias.
4. Microvascular angina (syndrome X)
a. Refers to the condition in patients with normal coronary angiograms and no coronary spasm but chest pain resembling angina and positive exercise test results.
b. Defective endothelium-dependent dilation in the coronary microcirculation may contribute to the altered regulation of myocardial perfusion and the ischemic manifestations in these patients.
c. Patients with chest pain and normal or nonobstructive coronary angiograms are predominantly women, and many have a prognosis that is not as benign as commonly thought (2% risk for death or myocardial infarction [MI] at 30 days of follow-up).
d. Useful therapeutic agents for symptom relief are β-blockers, angiotensin-converting enzyme (ACE) inhibitors, and tricyclic agents. Aggressive antiatherosclerotic therapy with statins should also be undertaken.
5. Refractory angina:
a. Refers to patients who, despite optimal medical therapy, have both angina and objective evidence of ischemia and are not considered candidates for revascularization.
b. Current U.S. Food and Drug Administration (FDA)-approved therapies consist of enhanced external counterpulsation (EECP), transcutaneous electrical nerve stimulation (TENS), and invasive therapies, such as spinal cord stimulation, transmyocardial revascularization, and percutaneous myocardial revascularization. Although some of these therapies may improve symptoms and quality of life, they have not been shown to decrease mortality.
6. Other: angina caused by aortic stenosis and idiopathic hypertrophic subaortic stenosis (IHSS), cocaine, or epinephrine-induced coronary vasoconstriction.